Background: Precision medicine increasingly relies on polygenic risk scores (PRS) to predict drug efficacy, safety, and therapeutic variability. Traditional monogenic pharmacogenetics, focused on individual gene variants, explains only 20-40% of drug response variation, leaving substantial "missing heritability." Polyg...
Irma Umar¹, Uzair Khalid², Sanwal Iqbal² et al.· Journal of Health, Wellness...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.